Gary J. Nabel, M.D., Ph.D.
DirectoratCandel Therapeutics· In the 2023 proxy
Gary J. Nabel, M.D., Ph.D. is Director of Candel Therapeutics.
Experience
- Candel TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +486%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?